Former NFL running back Chris Johnson has revealed he was diagnosed with amyotrophic lateral sclerosis (ALS) in 2023, ending years of speculation about his health struggles following a highly publicized retirement in 2013. The 40-year-old star, best known for his record-breaking 2009 season with 2,509 rushing yards, disclosed the diagnosis during an interview with a major U.S. morning television program, marking the first time he has publicly addressed the progressive neurodegenerative disease.
Johnson, who played 10 seasons in the NFL, including stints with the Tennessee Titans and New York Jets, said he began experiencing symptoms in late 2022 but did not seek a diagnosis until early 2023. According to medical experts, ALS—often referred to as Lou Gehrig’s disease—gradually affects nerve cells in the brain and spinal cord, leading to muscle weakness and, eventually, paralysis. Johnson’s revelation comes as part of a broader effort to raise awareness about the disease, which currently has no known cure.
ALS affects approximately 30,000 Americans at any given time, with an estimated 5,000 new diagnoses annually, according to the Amyotrophic Lateral Sclerosis Association (ALSA). The average lifespan after diagnosis is typically two to five years, though some individuals live for decades with the disease. Johnson’s case has drawn attention due to his high-profile career and the relatively early age at which he received his diagnosis.
Johnson’s announcement follows a period of declining public appearances and social media activity, which fans and former teammates had noted in recent years. In 2013, he retired abruptly after a series of injuries, including a severe ankle sprain that required surgery. While he has occasionally made appearances at NFL events and charitable functions, his health had remained a closely guarded secret until now.
Why Did Chris Johnson Wait So Long to Reveal His ALS Diagnosis?
Johnson’s decision to disclose his diagnosis publicly comes after months of speculation about his health. According to a close associate quoted in a New York Times report, the former player had been privately battling symptoms for nearly a year before seeking medical confirmation. The delay in diagnosis is not uncommon, as ALS symptoms—such as muscle weakness, slurred speech, or difficulty walking—can often be mistaken for other conditions.
ALS diagnosis typically involves a series of neurological tests, including electromyography (EMG) and magnetic resonance imaging (MRI), to rule out other potential causes of muscle deterioration. Johnson’s case aligns with recent medical research suggesting that early diagnosis remains challenging due to the disease’s varied progression. The ALS Association estimates that up to 30% of patients receive a diagnosis within a year of symptom onset, while others may wait significantly longer.
Johnson’s revelation also raises questions about the emotional and financial toll of living with ALS. According to the ALSA’s cost-of-care report, the average annual cost for ALS treatment and care exceeds $100,000 per patient. Many patients rely on insurance, charitable organizations, and government assistance to cover expenses, which can vary widely depending on the severity of symptoms.
How Has Chris Johnson’s Career and Public Persona Been Affected?
Johnson’s NFL career was defined by explosive performances, most notably his 2009 season, when he set a single-season rushing record with 2,509 yards—a mark that stood for nearly a decade before being broken by Adrian Peterson in 2012. His three Pro Bowl selections and Super Bowl XLIV appearance with the New Orleans Saints cemented his legacy as one of the most electrifying running backs of his era.
However, his career was cut short by a series of injuries, including a severe ankle sprain in 2012 that required surgery and contributed to his eventual retirement. Since leaving the NFL, Johnson has largely stayed out of the public eye, though he has remained active in charitable work, particularly through his foundation, which supports youth sports and education programs in Tennessee.
His decision to reveal his ALS diagnosis publicly may also serve as a platform to advocate for greater awareness and research funding. The ALS Association reports that only about 5% of ALS cases are hereditary, meaning the vast majority are sporadic, with no clear cause. Johnson’s high-profile status could help draw attention to the disease, which remains one of the most devastating neurological disorders.
What Happens Next for Chris Johnson and ALS Research?
Johnson has not yet specified his plans for treatment or public advocacy, but his disclosure could accelerate discussions around ALS research and patient support. The ALS Therapy Development Institute is currently funding over 50 clinical trials aimed at finding treatments to slow or halt the progression of the disease. While no cure exists, recent breakthroughs—such as the FDA-approved drug Riluzole (Rilutek) and Edaravone (Radicava)—have shown promise in extending the lives of some patients.
Johnson’s case may also prompt discussions about the long-term health of former NFL players, many of whom face higher risks of chronic traumatic encephalopathy (CTE) and other neurodegenerative diseases due to repeated head injuries. A 2022 study by the NFL found evidence of CTE in 110 of 111 brains donated by former players, though ALS is distinct from CTE and typically not linked to football-related injuries.
For now, Johnson’s focus appears to be on managing his condition and supporting others facing similar challenges. His foundation has already begun partnering with ALS organizations to provide resources for patients and their families. Fans and former teammates have expressed support, with many sharing messages of encouragement on social media.
Key Takeaways
- Diagnosis Delay: Johnson was diagnosed with ALS in early 2023 but did not disclose the news publicly until recently, highlighting the challenges of early detection.
- Career Impact: His NFL career ended abruptly in 2013 due to injuries, and his retirement has been followed by years of limited public appearances.
- Advocacy Potential: As a high-profile figure, Johnson’s disclosure could accelerate awareness and fundraising for ALS research.
- Treatment Options: While no cure exists, drugs like Riluzole and Edaravone have shown limited success in slowing disease progression.
- NFL Health Concerns: His case adds to ongoing discussions about the long-term health risks faced by former NFL players.
Where to Find More Information
For readers seeking additional details on ALS, the following resources provide authoritative information:
- Amyotrophic Lateral Sclerosis Association (ALSA) – Patient support, research updates, and treatment options.
- ALS Therapy Development Institute – Clinical trials and emerging therapies.
- National Institute of Neurological Disorders and Stroke (NINDS) – Medical research and diagnostic guidelines.
Chris Johnson’s announcement serves as a reminder of the ongoing need for research and support for ALS patients. As he navigates his diagnosis, his story may inspire others to seek early medical attention and contribute to the fight against this devastating disease.
Readers with additional questions or personal experiences related to ALS are encouraged to share their thoughts in the comments below. For updates on Johnson’s advocacy efforts, follow World Today Journal’s Sports section for the latest developments.